Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antitrust
MedTech
Thermo Fisher collects green lights for $3.1B Olink takeover
With a new go-ahead from antitrust regulators in the U.K., Thermo Fisher Scientific is on its way to closing its $3.1 billion deal for Olink.
Conor Hale
Jul 8, 2024 10:25am
Grail to become an Illumina spinout, once again, and go public
Jun 3, 2024 5:45pm
Illumina gets go-ahead from EU to part ways with Grail
Apr 12, 2024 10:11am
Sanofi scraps Maze deal after FTC throws up antitrust obstacles
Dec 12, 2023 6:00am
EU orders Illumina to split from Grail as penance for $8B deal
Oct 12, 2023 11:14am
EU order for Illumina to divest Grail coming soon: reports
Oct 11, 2023 10:33am
